查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1922966

人类消化器官系统模型市场（按产品类型、疾病、应用和最终用户划分）—2026-2032年全球预测

Human Digestive System Models Market by Product Type, Disease Focus, Application, End-User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 193 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2025 年，人体消化器官系统模型市场价值将达到 2.6782 亿美元，到 2026 年将成长至 3.0683 亿美元，到 2032 年将达到 5.8934 亿美元，复合年增长率为 11.92%。

关键市场统计数据
基准年 2025 2.6782亿美元
预计年份：2026年 3.0683亿美元
预测年份 2032 5.8934亿美元
复合年增长率 (%) 11.92%

策略指南概述了技术融合、相关人员驱动因素和应用优先事项，旨在重塑消化器官系统模型研究。

人类消化器官系统模型的研究已发展成为生物医学研究的关键领域，它融合了计算模拟、组织工程系统和动物实验，加速了科学发现和教育进程。计算流体力学和生理药物动力学建模的进步与动态细胞培养系统和类器官等先进的体外平台相辅相成，而精密的体内模型则为标靶研究提供了重要的转化背景。这些跨学科方法正在拓展研究人员、教育工作者和产业团队可用的工具，为探索吸收、微生物组-宿主相互作用和疾病病理病理学开闢了新的途径。

新兴的技术、监管和转化趋势正在重新定义消化器官系统模型如何提供可预测、可重复且与人类相关的见解。

消化器官系统建模的研究格局正在经历变革性变化，这主要得益于计算能力的提升、组织工程技术的进步以及对人类微生物组的日益关注。高精度计算流体力学和基于生理的药物动力学工具已从专用工具发展成为跨学科工作流程的核心要素，使得在实验开展前进行虚拟原型製作和假设完善成为可能。同时，动态细胞培养和类器官技术的创新正在提高模型的生理相关性和扩充性，从而缩小实验室研究与临床应用之间的转化差距。

2025年关税调整对科学研究基础设施与采购的影响：策略采购、流程重组与因应措施的必要性

2025年推出的关税和贸易措施重塑了整个研究界的采购模式、供应链和合作方式，促使人们重新审视供应商策略和业务连续性。进口试剂、专用硬体和仪器的关税带来的成本压力增加了许多建模平台的整体拥有成本，影响了产能集中布局和内部技术优先顺序。为此，学术和商业实验室正在积极推动供应来源多元化、区域采购和策略性库存管理，以减轻短期波动的影响。

综合細項分析揭示了产品类型、应用需求、最终用户优先事项和疾病关注点如何指导策略发展和应用。

細項分析揭示了不同的模型类型、应用、最终用户和疾病重点如何影响研究和商业化策略。产品类型包括计算模型、体外模型和体内模型，每种模型都有优点：计算方法，包括计算流体力学和基于生理的药物动力学模型，能够实现快速迭代和定量预测。体外平台（包括动态细胞培养、类器官和静态细胞培养）为机制研究和筛检研究提供可控制的生物环境，而体内模型（包括大型和小型动物模型）在需要时仍可用于系统性和整体性检验。

美洲、欧洲、中东和非洲以及亚太地区不同的区域趋势和能力建构模式，对采用、合作和商业化路径产生影响。

区域趋势对模型开发路径、合作网络和应用率有显着影响，美洲、欧洲、中东和非洲以及亚太地区呈现出截然不同的模式。在美洲，强大的产学研合作、高度集中的生物技术丛集以及大量的慈善和商业性研发投资正在推动先进体外平台和计算建模工具的快速应用。该地区通常作为创新试验场，用于测试优先考虑转化相关性和商业化潜力的整合工作流程。

影响平台差异化、伙伴关係模式和服务发展的竞争和製度因素，加速了消化器官系统模式的采用和检验。

主要企业和机构正透过有针对性的研发、策略伙伴关係和服务，推动消化器官系统模型平台的创新、检验框架和商业化路径。技术开发商透过提高生理保真度、扩充性和数据整合能力来脱颖而出，而受託研究机构和仪器製造商则专注于提高吞吐量、标准化和工作流程相容性，以满足学术界和工业界客户的多样化需求。领先的学术中心和研究机构致力于基础科学研究，并作为早期采用者检验新模型，以支援更广泛的应用部署。

为领导者提供加强消化器官系统建模中检验、应用一致性、供应链韧性和协作标准的实用策略建议

行业领导者必须采取务实且基于证据的策略，以提升消化器官系统建模的科学效用并创造价值。首先，他们应优先考虑互通性和验证性，设计能够与现有运算工具、多体学工作流程和成像系统无缝整合的平台，并提供能够经受跨实验室检验的互通性、可重复的资料集。投资于开放的检验资料集和易于取得的培训资源将加速技术应用，并增强学术界和商业用户之间的信任。

一种透明且可重复的混合方法调查方法，结合了专家访谈、文献综述和交叉检验，以实现可靠的模型评估。

本报告的调查方法结合了定性和定量方法，以确保研究结果的可靠性、可重复性以及结论的实用性。主要研究工作包括对来自学术机构、试管内受託研究机构(CRO)、製药公司和专业研究机构的专家进行访谈，以收集关于平台性能、实施挑战和未满足需求的第一手资讯。这些访谈旨在深入探讨计算、体外和体内等不同模式下的技术需求，并检验胃肠道和微生物组疾病的特异性研究考量。

策略意义的综合分析强调了检验、互通性和韧性对于消化器官系统模型转化和商业性成功的重要性。

我们的综合分析表明，消化器官系统模型处于创新、转化潜力和操作复杂性三者策略交汇点。计算建模、类器官和动态培养系统以及先进的体内方法的进步，构建了一个互补的格局，每种模型都根据应用场景提供独特的价值。营养研究、药物测试和医学教育各自采用不同的建模方法组合，凸显了针对特定用途进行选择和检验的重要性。

目录

第一章：序言

第二章调查方法

  • 研究设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查前提
  • 调查限制

第三章执行摘要

  • 首席主管观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会地图
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

8. 人体消化器官系统模型市场（依产品类型划分）

  • 计算模型
    • 计算流体力学
    • 基于生理的药物动力学模型
  • 体外模型
    • 动态细胞培养
    • 类器官
    • 静态细胞培养
  • 体内模型
    • 大型动物模型
    • 小型动物模型

9. 按疾病分類的人类消化器官系统模型市场

  • 胃肠道疾病
    • 发炎性肠道疾病
    • 大肠激躁症
  • 微生物组研究
    • 元基因组分析
    • 益生元和益生菌研究

第十章 人体消化器官系统模型市场（依应用领域划分）

  • 医学教育
  • 营养调查
    • 营养补充品的有效性
    • 微生物组交互作用研究
  • 药物测试
    • 药物吸收研究
    • 毒性评价

第十一章 人体消化器官系统模型市场（依最终用户划分）

  • 学术机构
  • 合约研究机构
  • 製药公司
  • 研究所

12. 各地区人体消化器官系统模型市场

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十三章 人体消化器官系统模型市场（依组别划分）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

14. 各国人体消化器官系统模型市场

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

15. 美国人体消化器官系统模型市场

第十六章 中国人体消化器官系统模型市场

第十七章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • 3B Scientific GmbH
  • 3D Systems, Inc.
  • Altay Scientific Group
  • Anatomical Chart Company, LLC
  • AnatomyTools
  • Denoyer-Geppert Co., Inc.
  • Erler-Zimmer GmbH
  • frasaco GmbH
  • GPI Anatomicals
  • Kyoto Kagaku Co., Ltd.
  • Laerdal Medical
  • Materialise NV
  • Medicraft, Inc.
  • NASCO Life Science
  • RealSim Medical
  • Simulab Corporation
  • SOMSO Modelle GmbH
  • Xincheng Scientific Industries
  • Yuan Technology Limited
Product Code: MRR-867BED9A9E8B

The Human Digestive System Models Market was valued at USD 267.82 million in 2025 and is projected to grow to USD 306.83 million in 2026, with a CAGR of 11.92%, reaching USD 589.34 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 267.82 million
Estimated Year [2026] USD 306.83 million
Forecast Year [2032] USD 589.34 million
CAGR (%) 11.92%

A strategic orientation outlining the technological convergence, stakeholder drivers, and translational priorities reshaping digestive system model research

The study of human digestive system models has matured into a pivotal area of biomedical research that bridges computational simulation, engineered tissue systems, and animal studies to accelerate discovery and education. Advances in computational fluid dynamics and physiologically based pharmacokinetic modeling now complement sophisticated in vitro platforms such as dynamic cell culture systems and organoids, while refined in vivo models provide translational context that remains indispensable for targeted investigations. These converging approaches have broadened the toolkit available to investigators, educators, and industry teams, creating new pathways to interrogate absorption, microbiome-host interactions, and disease pathophysiology.

This introduction frames the drivers that have elevated digestive system modeling from a niche technical domain into a strategic asset for multiple stakeholders. Academic groups leverage these models to deepen mechanistic understanding and train the next generation of clinicians and scientists. Contract research organizations and pharmaceutical companies integrate modeling approaches to de-risk candidate selection and refine toxicology assessment. Nutritional researchers deploy organoids and metagenomic analysis to study prebiotic and probiotic effects at unprecedented resolution. Throughout, regulatory expectations for translational relevance and reproducibility are sharpening, compelling model developers to align validation practices with end-user needs.

Moving forward, the landscape will prioritize model interoperability, data standardization, and pragmatic validation frameworks. Stakeholders who combine technical rigor with clear application pathways will realize the most immediate impact, driving innovation that is both scientifically robust and operationally relevant.

Emerging technological, regulatory, and translational dynamics that are redefining how digestive system models deliver predictive, reproducible, and human-relevant insights

The landscape for digestive system models is undergoing transformative shifts driven by advances in computational power, tissue engineering, and an intensified focus on the human microbiome. High-fidelity computational fluid dynamics and physiologically based pharmacokinetic tools have evolved from specialized utilities into core elements of cross-disciplinary workflows, enabling virtual prototyping and hypothesis refinement prior to experimental commitment. Concurrently, innovations in dynamic cell culture and organoid technologies have improved physiological relevance and scalability, narrowing the translational gap between bench and bedside.

Regulatory and funding environments now reward reproducibility and human-relevant data, which incentivizes the development of standardized validation protocols and interlaboratory benchmarking. This trend accelerates the adoption of integrated approaches that combine in silico models with in vitro systems and selective in vivo studies to provide layered evidence supporting safety, efficacy, and mechanism. Industry players are responding by optimizing platforms for throughput, data integration, and compatibility with advanced analytics such as multi-omics readouts and machine learning.

As a result, stakeholders are rethinking research pipelines to emphasize model selection that aligns with specific application requirements-whether for medical education, nutritional intervention testing, or complex drug absorption studies. The net effect is a more efficient, predictive, and ethically considered research ecosystem that captures biological complexity while reducing unnecessary experimentation.

How 2025 tariff-related disruptions have prompted strategic sourcing, collaboration reconfiguration, and resilience measures across research infrastructure and procurement

The introduction of tariffs and trade measures in 2025 has reshaped procurement patterns, supply chains, and collaboration across research communities, prompting a recalibration of vendor strategies and operational resilience. Tariff-driven cost pressures on imported reagents, specialized hardware, and instrumentation have increased the total cost of ownership for many modeling platforms, influencing decisions about where to centralize capabilities and which technologies to prioritize for in-house development. In response, academic institutions and commercial laboratories have pursued supply diversification, regional sourcing, and strategic inventory stewardship to buffer short-term volatility.

These dynamics have also influenced collaborative frameworks. Cross-border partnerships now place greater emphasis on local manufacturing, data-sharing agreements that minimize physical transfer of sensitive materials, and virtual collaboration leveraging computational models to offset constraints on experimental exchange. Funding bodies and procurement offices are increasingly attentive to the trade-related risk embedded in long-term research programs, encouraging contingency planning and contractual clauses that account for tariff fluctuations.

Despite added complexity, the effect has driven some positive outcomes: investment in domestic manufacturing capabilities for critical consumables has spurred innovation and shortened lead times, while reliance on computational and in vitro approaches has accelerated as teams seek to reduce dependency on imported animal models and high-cost instrumentation. The net impact is a more diversified and resilient research infrastructure-one that emphasizes flexible sourcing, stronger supply chain risk management, and pragmatic integration of modeling modalities to sustain research continuity.

Integrated segmentation analysis revealing how product typologies, application demands, end-user priorities, and disease focus direct strategic development and adoption

Insights from segmentation reveal how differentiated model types, applications, end users, and disease priorities are shaping research and commercialization strategies. Product-type distinctions encompass computational models, in vitro models, and in vivo models, each offering unique strengths: computational approaches, including computational fluid dynamics and physiologically based pharmacokinetic models, enable rapid iteration and quantitative prediction; in vitro platforms, spanning dynamic cell culture, organoids, and static cell culture, deliver controlled biological contexts for mechanistic and screening studies; while in vivo options, comprising large and small animal models, remain critical for systemic and whole-organism validation where required.

Application-driven segmentation clarifies where demand concentrates: medical education benefits from reproducible models that illustrate physiology and pathology at scale, nutritional research leverages models to evaluate dietary supplement efficacy and microbiome interaction studies, and pharmaceutical testing employs models for drug absorption studies and toxicology assessment. End-user segmentation demonstrates distinct priorities across academic institutions, contract research organizations, pharmaceutical companies, and research institutes, with academic groups emphasizing mechanistic discovery and training, CROs focusing on throughput and regulatory alignment, pharmaceutical sponsors prioritizing translational predictability, and research institutes balancing innovation with collaborative initiatives.

Disease-focused segmentation further refines strategic choices. Gastrointestinal disorders, including inflammatory bowel disease and irritable bowel syndrome, demand models that reflect tissue architecture and chronic inflammatory processes, while microbiome research-encompassing metagenomic analysis and prebiotic and probiotic studies-requires platforms capable of simulating host-microbe interactions and enabling multi-omics interrogation. Together, these segmentation lenses inform targeted investment in model validation, platform interoperability, and end-user training programs that accelerate adoption across use cases.

Distinct regional trends and capacity-building patterns across the Americas, Europe, Middle East & Africa, and Asia-Pacific that influence adoption, collaboration, and commercialization pathways

Regional dynamics exert a strong influence on model development pathways, collaborative networks, and adoption rates, with distinct patterns emerging across the Americas, Europe, Middle East & Africa, and Asia-Pacific. In the Americas, robust academic-industry partnerships, concentrated biotechnology clusters, and significant philanthropic and commercial R&D investment drive rapid uptake of advanced in vitro platforms and computational modeling tools. This region often serves as an innovation testbed for integrated workflows that prioritize translational relevance and commercialization potential.

Across Europe, the Middle East & Africa, regulatory alignment and collaborative consortia have prompted harmonization efforts around standards, validation, and ethical use of models. European research networks emphasize reproducibility and cross-institutional benchmarking, while specific pockets within the Middle East and Africa are building capacity through targeted investments and international collaborations to strengthen local research infrastructure. These dynamics encourage platform developers to focus on interoperability, compliance, and training resources that facilitate cross-border studies.

The Asia-Pacific region exhibits rapid capacity expansion, with significant investments in biotechnology manufacturing, organoid research, and computational infrastructure. Large-scale academic programs and increasing private sector engagement are accelerating adoption, especially where local manufacturing can mitigate supply chain constraints and tariff impacts. Across regions, the convergence of policy, funding, and market maturity shapes where technologies scale first and how partnerships are structured to deliver scientific and commercial impact.

Competitive behaviors and institutional drivers shaping platform differentiation, partnership models, and services that accelerate adoption and validation of digestive system models

Key companies and institutional actors are driving platform innovation, validation frameworks, and commercial pathways for digestive system models through targeted R&D, strategic partnerships, and service offerings. Technology developers are differentiating via improved physiological fidelity, scalability, and data integration capabilities, while contract research organizations and instrument manufacturers focus on throughput, standardization, and workflow compatibility to meet the diverse needs of academic and industry customers. Leading academic centers and research institutes contribute foundational science and act as early adopters that validate new models for broader translation.

Competitive positioning increasingly depends on demonstrable reproducibility, integration with multi-omics and imaging modalities, and the ability to deliver regulatory-grade evidence when required. Partnerships between computational tool providers and experimental platform developers are common, enabling hybrid solutions that combine in silico prediction with targeted experimental confirmation. Service-oriented firms that offer end-to-end support-from model selection and validation to data analysis and regulatory consultation-are capturing demand from organizations seeking turnkey capabilities.

In this environment, companies that invest in open validation datasets, training programs, and strong customer support gain trust and broader adoption. Institutional collaborations and consortia that center on standard-setting also play a pivotal role in accelerating market maturation and lowering barriers for newcomers focused on specialized disease areas or applications.

Actionable strategic recommendations for leaders to enhance validation, application alignment, supply chain resilience, and collaborative standards in digestive system modeling

Industry leaders must adopt pragmatic, evidence-driven strategies to capture value and advance scientific utility across digestive system modeling. First, prioritize interoperability and validation by designing platforms that integrate seamlessly with established computational tools, multi-omics workflows, and imaging systems while delivering robust, reproducible datasets that stand up to cross-laboratory benchmarking. Investing in open validation datasets and accessible training resources will accelerate adoption and strengthen trust among academic and commercial users.

Second, tailor go-to-market approaches by aligning product roadmaps with application-specific needs. For medical education, emphasize reproducibility and pedagogical resources; for nutritional research, optimize models to investigate dietary supplement efficacy and host-microbe interactions; for pharmaceutical testing, focus on evidence that supports drug absorption and toxicology assessment. Engaging end users-academic institutions, CROs, pharmaceutical companies, and research institutes-early in development ensures practical fit and reduces adoption friction.

Third, strengthen supply chain resilience and regional partnerships to mitigate tariff and procurement risks. Localizing critical consumable production, diversifying supplier networks, and creating contingency sourcing plans will protect program continuity. Finally, foster collaborative consortia that co-develop standards and benchmarking initiatives to accelerate regulatory acceptance and create a level playing field for innovation. These actions collectively will position industry leaders to deliver scientifically rigorous, operationally viable solutions that meet evolving stakeholder expectations.

Transparent and reproducible mixed-methods research methodology combining expert interviews, literature synthesis, and cross-validation for credible model assessment

The research methodology supporting this report combined qualitative and quantitative approaches to ensure robust, reproducible findings and actionable conclusions. Primary research included interviews with subject matter experts across academic institutions, contract research organizations, pharmaceutical companies, and specialized research institutes, capturing firsthand perspectives on platform performance, adoption challenges, and unmet needs. These interviews were structured to probe technical requirements across computational, in vitro, and in vivo modalities and to validate disease-specific considerations for gastrointestinal disorders and microbiome-focused investigations.

Secondary research synthesized peer-reviewed literature, regulatory guidance documents, and technology roadmaps to contextualize primary insights and ensure alignment with best practices in model validation and translational research. Comparative analysis examined platform capabilities such as computational fluid dynamics and physiologically based pharmacokinetic modeling, dynamic and static cell culture systems, organoid technologies, and various animal model formats to map strengths, limitations, and fit-for-purpose applications.

Cross-validation steps included triangulation of interview findings with experimental case studies and reproducibility reports, as well as review by technical advisory contributors with expertise in metagenomics, pharmacokinetics, and gastrointestinal disease models. The methodology emphasized transparency, replicability, and stakeholder validation to support credible recommendations and to inform practical decision-making for both developers and end users.

Synthesis of strategic implications highlighting validation, interoperability, and resilience as the levers that will determine the translational and commercial success of digestive system models

The collective analysis underscores that digestive system models occupy a strategic nexus of innovation, translational potential, and operational complexity. Advances in computational modeling, organoid and dynamic culture systems, and refined in vivo approaches have created a complementary landscape in which each modality contributes distinct value depending on application needs. Nutritional research, pharmaceutical testing, and medical education each draw on different combinations of modeling approaches, reinforcing the importance of match-for-purpose selection and validation.

Regional dynamics, trade-related pressures, and stakeholder expectations for reproducibility and regulatory relevance are reshaping how organizations invest in capabilities and structure collaborations. As a result, resilient supply chain strategies, interoperable platforms, and collaborative standard-setting initiatives will determine which technologies scale rapidly and which require further maturation. Companies and institutions that focus on demonstrable validation, user-centric design, and strategic partnerships will be best positioned to capture scientific and commercial value.

In conclusion, the future trajectory of digestive system modeling is bright but contingent on disciplined validation, thoughtful alignment with end-user workflows, and proactive management of external risks. Those who integrate technical excellence with pragmatic commercialization and collaboration strategies will accelerate the translation of model-driven insights into meaningful research, therapeutic, and educational outcomes.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Human Digestive System Models Market, by Product Type

  • 8.1. Computational Models
    • 8.1.1. Computational Fluid Dynamics
    • 8.1.2. Physiologically Based Pharmacokinetic
  • 8.2. In Vitro Models
    • 8.2.1. Dynamic Cell Culture
    • 8.2.2. Organoids
    • 8.2.3. Static Cell Culture
  • 8.3. In Vivo Models
    • 8.3.1. Large Animal Models
    • 8.3.2. Small Animal Models

9. Human Digestive System Models Market, by Disease Focus

  • 9.1. Gastrointestinal Disorders
    • 9.1.1. Inflammatory Bowel Disease
    • 9.1.2. Irritable Bowel Syndrome
  • 9.2. Microbiome Research
    • 9.2.1. Metagenomic Analysis
    • 9.2.2. Prebiotics And Probiotics Studies

10. Human Digestive System Models Market, by Application

  • 10.1. Medical Education
  • 10.2. Nutritional Research
    • 10.2.1. Dietary Supplement Efficacy
    • 10.2.2. Microbiome Interaction Studies
  • 10.3. Pharmaceutical Testing
    • 10.3.1. Drug Absorption Studies
    • 10.3.2. Toxicology Assessment

11. Human Digestive System Models Market, by End-User

  • 11.1. Academic Institutions
  • 11.2. Contract Research Organizations
  • 11.3. Pharmaceutical Companies
  • 11.4. Research Institutes

12. Human Digestive System Models Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Human Digestive System Models Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Human Digestive System Models Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States Human Digestive System Models Market

16. China Human Digestive System Models Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. 3B Scientific GmbH
  • 17.6. 3D Systems, Inc.
  • 17.7. Altay Scientific Group
  • 17.8. Anatomical Chart Company, LLC
  • 17.9. AnatomyTools
  • 17.10. Denoyer-Geppert Co., Inc.
  • 17.11. Erler-Zimmer GmbH
  • 17.12. frasaco GmbH
  • 17.13. GPI Anatomicals
  • 17.14. Kyoto Kagaku Co., Ltd.
  • 17.15. Laerdal Medical
  • 17.16. Materialise NV
  • 17.17. Medicraft, Inc.
  • 17.18. NASCO Life Science
  • 17.19. RealSim Medical
  • 17.20. Simulab Corporation
  • 17.21. SOMSO Modelle GmbH
  • 17.22. Xincheng Scientific Industries
  • 17.23. Yuan Technology Limited

LIST OF FIGURES

  • FIGURE 1. GLOBAL HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL HUMAN DIGESTIVE SYSTEM MODELS MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL HUMAN DIGESTIVE SYSTEM MODELS MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, BY DISEASE FOCUS, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, BY END-USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, BY COMPUTATIONAL MODELS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, BY COMPUTATIONAL MODELS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, BY COMPUTATIONAL MODELS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, BY COMPUTATIONAL MODELS, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, BY COMPUTATIONAL FLUID DYNAMICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, BY COMPUTATIONAL FLUID DYNAMICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, BY COMPUTATIONAL FLUID DYNAMICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, BY PHYSIOLOGICALLY BASED PHARMACOKINETIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, BY PHYSIOLOGICALLY BASED PHARMACOKINETIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, BY PHYSIOLOGICALLY BASED PHARMACOKINETIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, BY IN VITRO MODELS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, BY IN VITRO MODELS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, BY IN VITRO MODELS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, BY IN VITRO MODELS, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, BY DYNAMIC CELL CULTURE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, BY DYNAMIC CELL CULTURE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, BY DYNAMIC CELL CULTURE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, BY ORGANOIDS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, BY ORGANOIDS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, BY ORGANOIDS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, BY STATIC CELL CULTURE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, BY STATIC CELL CULTURE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, BY STATIC CELL CULTURE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, BY IN VIVO MODELS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, BY IN VIVO MODELS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, BY IN VIVO MODELS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, BY IN VIVO MODELS, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, BY LARGE ANIMAL MODELS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, BY LARGE ANIMAL MODELS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, BY LARGE ANIMAL MODELS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, BY SMALL ANIMAL MODELS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, BY SMALL ANIMAL MODELS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, BY SMALL ANIMAL MODELS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, BY DISEASE FOCUS, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, BY GASTROINTESTINAL DISORDERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, BY GASTROINTESTINAL DISORDERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, BY GASTROINTESTINAL DISORDERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, BY GASTROINTESTINAL DISORDERS, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, BY INFLAMMATORY BOWEL DISEASE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, BY INFLAMMATORY BOWEL DISEASE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, BY INFLAMMATORY BOWEL DISEASE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, BY IRRITABLE BOWEL SYNDROME, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, BY IRRITABLE BOWEL SYNDROME, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, BY IRRITABLE BOWEL SYNDROME, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, BY MICROBIOME RESEARCH, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, BY MICROBIOME RESEARCH, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, BY MICROBIOME RESEARCH, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, BY MICROBIOME RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, BY METAGENOMIC ANALYSIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, BY METAGENOMIC ANALYSIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, BY METAGENOMIC ANALYSIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, BY PREBIOTICS AND PROBIOTICS STUDIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, BY PREBIOTICS AND PROBIOTICS STUDIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, BY PREBIOTICS AND PROBIOTICS STUDIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, BY MEDICAL EDUCATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, BY MEDICAL EDUCATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, BY MEDICAL EDUCATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, BY NUTRITIONAL RESEARCH, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, BY NUTRITIONAL RESEARCH, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, BY NUTRITIONAL RESEARCH, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, BY NUTRITIONAL RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, BY DIETARY SUPPLEMENT EFFICACY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, BY DIETARY SUPPLEMENT EFFICACY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, BY DIETARY SUPPLEMENT EFFICACY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, BY MICROBIOME INTERACTION STUDIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, BY MICROBIOME INTERACTION STUDIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, BY MICROBIOME INTERACTION STUDIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, BY PHARMACEUTICAL TESTING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, BY PHARMACEUTICAL TESTING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, BY PHARMACEUTICAL TESTING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, BY PHARMACEUTICAL TESTING, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, BY DRUG ABSORPTION STUDIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, BY DRUG ABSORPTION STUDIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, BY DRUG ABSORPTION STUDIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, BY TOXICOLOGY ASSESSMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, BY TOXICOLOGY ASSESSMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, BY TOXICOLOGY ASSESSMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, BY ACADEMIC INSTITUTIONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, BY ACADEMIC INSTITUTIONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, BY ACADEMIC INSTITUTIONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 95. AMERICAS HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 96. AMERICAS HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 97. AMERICAS HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, BY COMPUTATIONAL MODELS, 2018-2032 (USD MILLION)
  • TABLE 98. AMERICAS HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, BY IN VITRO MODELS, 2018-2032 (USD MILLION)
  • TABLE 99. AMERICAS HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, BY IN VIVO MODELS, 2018-2032 (USD MILLION)
  • TABLE 100. AMERICAS HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, BY DISEASE FOCUS, 2018-2032 (USD MILLION)
  • TABLE 101. AMERICAS HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, BY GASTROINTESTINAL DISORDERS, 2018-2032 (USD MILLION)
  • TABLE 102. AMERICAS HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, BY MICROBIOME RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 103. AMERICAS HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 104. AMERICAS HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, BY NUTRITIONAL RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 105. AMERICAS HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, BY PHARMACEUTICAL TESTING, 2018-2032 (USD MILLION)
  • TABLE 106. AMERICAS HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 107. NORTH AMERICA HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 108. NORTH AMERICA HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 109. NORTH AMERICA HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, BY COMPUTATIONAL MODELS, 2018-2032 (USD MILLION)
  • TABLE 110. NORTH AMERICA HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, BY IN VITRO MODELS, 2018-2032 (USD MILLION)
  • TABLE 111. NORTH AMERICA HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, BY IN VIVO MODELS, 2018-2032 (USD MILLION)
  • TABLE 112. NORTH AMERICA HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, BY DISEASE FOCUS, 2018-2032 (USD MILLION)
  • TABLE 113. NORTH AMERICA HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, BY GASTROINTESTINAL DISORDERS, 2018-2032 (USD MILLION)
  • TABLE 114. NORTH AMERICA HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, BY MICROBIOME RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 115. NORTH AMERICA HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 116. NORTH AMERICA HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, BY NUTRITIONAL RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 117. NORTH AMERICA HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, BY PHARMACEUTICAL TESTING, 2018-2032 (USD MILLION)
  • TABLE 118. NORTH AMERICA HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 119. LATIN AMERICA HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 120. LATIN AMERICA HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 121. LATIN AMERICA HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, BY COMPUTATIONAL MODELS, 2018-2032 (USD MILLION)
  • TABLE 122. LATIN AMERICA HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, BY IN VITRO MODELS, 2018-2032 (USD MILLION)
  • TABLE 123. LATIN AMERICA HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, BY IN VIVO MODELS, 2018-2032 (USD MILLION)
  • TABLE 124. LATIN AMERICA HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, BY DISEASE FOCUS, 2018-2032 (USD MILLION)
  • TABLE 125. LATIN AMERICA HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, BY GASTROINTESTINAL DISORDERS, 2018-2032 (USD MILLION)
  • TABLE 126. LATIN AMERICA HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, BY MICROBIOME RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 127. LATIN AMERICA HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 128. LATIN AMERICA HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, BY NUTRITIONAL RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 129. LATIN AMERICA HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, BY PHARMACEUTICAL TESTING, 2018-2032 (USD MILLION)
  • TABLE 130. LATIN AMERICA HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 131. EUROPE, MIDDLE EAST & AFRICA HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 132. EUROPE, MIDDLE EAST & AFRICA HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 133. EUROPE, MIDDLE EAST & AFRICA HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, BY COMPUTATIONAL MODELS, 2018-2032 (USD MILLION)
  • TABLE 134. EUROPE, MIDDLE EAST & AFRICA HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, BY IN VITRO MODELS, 2018-2032 (USD MILLION)
  • TABLE 135. EUROPE, MIDDLE EAST & AFRICA HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, BY IN VIVO MODELS, 2018-2032 (USD MILLION)
  • TABLE 136. EUROPE, MIDDLE EAST & AFRICA HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, BY DISEASE FOCUS, 2018-2032 (USD MILLION)
  • TABLE 137. EUROPE, MIDDLE EAST & AFRICA HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, BY GASTROINTESTINAL DISORDERS, 2018-2032 (USD MILLION)
  • TABLE 138. EUROPE, MIDDLE EAST & AFRICA HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, BY MICROBIOME RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 139. EUROPE, MIDDLE EAST & AFRICA HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 140. EUROPE, MIDDLE EAST & AFRICA HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, BY NUTRITIONAL RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 141. EUROPE, MIDDLE EAST & AFRICA HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, BY PHARMACEUTICAL TESTING, 2018-2032 (USD MILLION)
  • TABLE 142. EUROPE, MIDDLE EAST & AFRICA HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 143. EUROPE HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 144. EUROPE HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 145. EUROPE HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, BY COMPUTATIONAL MODELS, 2018-2032 (USD MILLION)
  • TABLE 146. EUROPE HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, BY IN VITRO MODELS, 2018-2032 (USD MILLION)
  • TABLE 147. EUROPE HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, BY IN VIVO MODELS, 2018-2032 (USD MILLION)
  • TABLE 148. EUROPE HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, BY DISEASE FOCUS, 2018-2032 (USD MILLION)
  • TABLE 149. EUROPE HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, BY GASTROINTESTINAL DISORDERS, 2018-2032 (USD MILLION)
  • TABLE 150. EUROPE HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, BY MICROBIOME RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 151. EUROPE HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 152. EUROPE HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, BY NUTRITIONAL RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 153. EUROPE HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, BY PHARMACEUTICAL TESTING, 2018-2032 (USD MILLION)
  • TABLE 154. EUROPE HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 155. MIDDLE EAST HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 156. MIDDLE EAST HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 157. MIDDLE EAST HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, BY COMPUTATIONAL MODELS, 2018-2032 (USD MILLION)
  • TABLE 158. MIDDLE EAST HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, BY IN VITRO MODELS, 2018-2032 (USD MILLION)
  • TABLE 159. MIDDLE EAST HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, BY IN VIVO MODELS, 2018-2032 (USD MILLION)
  • TABLE 160. MIDDLE EAST HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, BY DISEASE FOCUS, 2018-2032 (USD MILLION)
  • TABLE 161. MIDDLE EAST HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, BY GASTROINTESTINAL DISORDERS, 2018-2032 (USD MILLION)
  • TABLE 162. MIDDLE EAST HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, BY MICROBIOME RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 163. MIDDLE EAST HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 164. MIDDLE EAST HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, BY NUTRITIONAL RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 165. MIDDLE EAST HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, BY PHARMACEUTICAL TESTING, 2018-2032 (USD MILLION)
  • TABLE 166. MIDDLE EAST HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 167. AFRICA HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 168. AFRICA HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 169. AFRICA HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, BY COMPUTATIONAL MODELS, 2018-2032 (USD MILLION)
  • TABLE 170. AFRICA HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, BY IN VITRO MODELS, 2018-2032 (USD MILLION)
  • TABLE 171. AFRICA HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, BY IN VIVO MODELS, 2018-2032 (USD MILLION)
  • TABLE 172. AFRICA HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, BY DISEASE FOCUS, 2018-2032 (USD MILLION)
  • TABLE 173. AFRICA HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, BY GASTROINTESTINAL DISORDERS, 2018-2032 (USD MILLION)
  • TABLE 174. AFRICA HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, BY MICROBIOME RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 175. AFRICA HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 176. AFRICA HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, BY NUTRITIONAL RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 177. AFRICA HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, BY PHARMACEUTICAL TESTING, 2018-2032 (USD MILLION)
  • TABLE 178. AFRICA HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 179. ASIA-PACIFIC HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 180. ASIA-PACIFIC HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 181. ASIA-PACIFIC HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, BY COMPUTATIONAL MODELS, 2018-2032 (USD MILLION)
  • TABLE 182. ASIA-PACIFIC HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, BY IN VITRO MODELS, 2018-2032 (USD MILLION)
  • TABLE 183. ASIA-PACIFIC HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, BY IN VIVO MODELS, 2018-2032 (USD MILLION)
  • TABLE 184. ASIA-PACIFIC HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, BY DISEASE FOCUS, 2018-2032 (USD MILLION)
  • TABLE 185. ASIA-PACIFIC HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, BY GASTROINTESTINAL DISORDERS, 2018-2032 (USD MILLION)
  • TABLE 186. ASIA-PACIFIC HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, BY MICROBIOME RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 187. ASIA-PACIFIC HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 188. ASIA-PACIFIC HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, BY NUTRITIONAL RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 189. ASIA-PACIFIC HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, BY PHARMACEUTICAL TESTING, 2018-2032 (USD MILLION)
  • TABLE 190. ASIA-PACIFIC HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 191. GLOBAL HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 192. ASEAN HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 193. ASEAN HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 194. ASEAN HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, BY COMPUTATIONAL MODELS, 2018-2032 (USD MILLION)
  • TABLE 195. ASEAN HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, BY IN VITRO MODELS, 2018-2032 (USD MILLION)
  • TABLE 196. ASEAN HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, BY IN VIVO MODELS, 2018-2032 (USD MILLION)
  • TABLE 197. ASEAN HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, BY DISEASE FOCUS, 2018-2032 (USD MILLION)
  • TABLE 198. ASEAN HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, BY GASTROINTESTINAL DISORDERS, 2018-2032 (USD MILLION)
  • TABLE 199. ASEAN HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, BY MICROBIOME RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 200. ASEAN HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 201. ASEAN HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, BY NUTRITIONAL RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 202. ASEAN HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, BY PHARMACEUTICAL TESTING, 2018-2032 (USD MILLION)
  • TABLE 203. ASEAN HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 204. GCC HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 205. GCC HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 206. GCC HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, BY COMPUTATIONAL MODELS, 2018-2032 (USD MILLION)
  • TABLE 207. GCC HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, BY IN VITRO MODELS, 2018-2032 (USD MILLION)
  • TABLE 208. GCC HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, BY IN VIVO MODELS, 2018-2032 (USD MILLION)
  • TABLE 209. GCC HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, BY DISEASE FOCUS, 2018-2032 (USD MILLION)
  • TABLE 210. GCC HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, BY GASTROINTESTINAL DISORDERS, 2018-2032 (USD MILLION)
  • TABLE 211. GCC HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, BY MICROBIOME RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 212. GCC HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 213. GCC HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, BY NUTRITIONAL RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 214. GCC HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, BY PHARMACEUTICAL TESTING, 2018-2032 (USD MILLION)
  • TABLE 215. GCC HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 216. EUROPEAN UNION HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 217. EUROPEAN UNION HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 218. EUROPEAN UNION HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, BY COMPUTATIONAL MODELS, 2018-2032 (USD MILLION)
  • TABLE 219. EUROPEAN UNION HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, BY IN VITRO MODELS, 2018-2032 (USD MILLION)
  • TABLE 220. EUROPEAN UNION HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, BY IN VIVO MODELS, 2018-2032 (USD MILLION)
  • TABLE 221. EUROPEAN UNION HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, BY DISEASE FOCUS, 2018-2032 (USD MILLION)
  • TABLE 222. EUROPEAN UNION HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, BY GASTROINTESTINAL DISORDERS, 2018-2032 (USD MILLION)
  • TABLE 223. EUROPEAN UNION HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, BY MICROBIOME RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 224. EUROPEAN UNION HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 225. EUROPEAN UNION HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, BY NUTRITIONAL RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 226. EUROPEAN UNION HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, BY PHARMACEUTICAL TESTING, 2018-2032 (USD MILLION)
  • TABLE 227. EUROPEAN UNION HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 228. BRICS HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 229. BRICS HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 230. BRICS HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, BY COMPUTATIONAL MODELS, 2018-2032 (USD MILLION)
  • TABLE 231. BRICS HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, BY IN VITRO MODELS, 2018-2032 (USD MILLION)
  • TABLE 232. BRICS HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, BY IN VIVO MODELS, 2018-2032 (USD MILLION)
  • TABLE 233. BRICS HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, BY DISEASE FOCUS, 2018-2032 (USD MILLION)
  • TABLE 234. BRICS HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, BY GASTROINTESTINAL DISORDERS, 2018-2032 (USD MILLION)
  • TABLE 235. BRICS HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, BY MICROBIOME RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 236. BRICS HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 237. BRICS HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, BY NUTRITIONAL RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 238. BRICS HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, BY PHARMACEUTICAL TESTING, 2018-2032 (USD MILLION)
  • TABLE 239. BRICS HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 240. G7 HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 241. G7 HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 242. G7 HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, BY COMPUTATIONAL MODELS, 2018-2032 (USD MILLION)
  • TABLE 243. G7 HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, BY IN VITRO MODELS, 2018-2032 (USD MILLION)
  • TABLE 244. G7 HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, BY IN VIVO MODELS, 2018-2032 (USD MILLION)
  • TABLE 245. G7 HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, BY DISEASE FOCUS, 2018-2032 (USD MILLION)
  • TABLE 246. G7 HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, BY GASTROINTESTINAL DISORDERS, 2018-2032 (USD MILLION)
  • TABLE 247. G7 HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, BY MICROBIOME RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 248. G7 HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 249. G7 HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, BY NUTRITIONAL RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 250. G7 HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, BY PHARMACEUTICAL TESTING, 2018-2032 (USD MILLION)
  • TABLE 251. G7 HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 252. NATO HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 253. NATO HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 254. NATO HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, BY COMPUTATIONAL MODELS, 2018-2032 (USD MILLION)
  • TABLE 255. NATO HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, BY IN VITRO MODELS, 2018-2032 (USD MILLION)
  • TABLE 256. NATO HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, BY IN VIVO MODELS, 2018-2032 (USD MILLION)
  • TABLE 257. NATO HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, BY DISEASE FOCUS, 2018-2032 (USD MILLION)
  • TABLE 258. NATO HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, BY GASTROINTESTINAL DISORDERS, 2018-2032 (USD MILLION)
  • TABLE 259. NATO HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, BY MICROBIOME RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 260. NATO HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 261. NATO HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, BY NUTRITIONAL RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 262. NATO HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, BY PHARMACEUTICAL TESTING, 2018-2032 (USD MILLION)
  • TABLE 263. NATO HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 264. GLOBAL HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 265. UNITED STATES HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 266. UNITED STATES HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 267. UNITED STATES HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, BY COMPUTATIONAL MODELS, 2018-2032 (USD MILLION)
  • TABLE 268. UNITED STATES HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, BY IN VITRO MODELS, 2018-2032 (USD MILLION)
  • TABLE 269. UNITED STATES HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, BY IN VIVO MODELS, 2018-2032 (USD MILLION)
  • TABLE 270. UNITED STATES HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, BY DISEASE FOCUS, 2018-2032 (USD MILLION)
  • TABLE 271. UNITED STATES HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, BY GASTROINTESTINAL DISORDERS, 2018-2032 (USD MILLION)
  • TABLE 272. UNITED STATES HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, BY MICROBIOME RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 273. UNITED STATES HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 274. UNITED STATES HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, BY NUTRITIONAL RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 275. UNITED STATES HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, BY PHARMACEUTICAL TESTING, 2018-2032 (USD MILLION)
  • TABLE 276. UNITED STATES HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 277. CHINA HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 278. CHINA HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 279. CHINA HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, BY COMPUTATIONAL MODELS, 2018-2032 (USD MILLION)
  • TABLE 280. CHINA HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, BY IN VITRO MODELS, 2018-2032 (USD MILLION)
  • TABLE 281. CHINA HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, BY IN VIVO MODELS, 2018-2032 (USD MILLION)
  • TABLE 282. CHINA HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, BY DISEASE FOCUS, 2018-2032 (USD MILLION)
  • TABLE 283. CHINA HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, BY GASTROINTESTINAL DISORDERS, 2018-2032 (USD MILLION)
  • TABLE 284. CHINA HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, BY MICROBIOME RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 285. CHINA HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 286. CHINA HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, BY NUTRITIONAL RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 287. CHINA HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, BY PHARMACEUTICAL TESTING, 2018-2032 (USD MILLION)
  • TABLE 288. CHINA HUMAN DIGESTIVE SYSTEM MODELS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)